Allergy Asthma Immunol Res.  2017 Nov;9(6):463-465. 10.4168/aair.2017.9.6.463.

Effective Strategies for Managing Asthma Exacerbations for Precision Medicine

• Cho YS

• KMID: 2421655
• DOI: http://doi.org/10.4168/aair.2017.9.6.463

Abstract

No abstract available.

MeSH Terms

Asthma*
Precision Medicine*

Reference

1. Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012; 129:1229–1235.

2. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011; 127:145–152.

3. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009; 179:19–24.

4. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007; 30:452–456.

5. Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. Jama. 2004; 292:367–376.

6. Kim MA, Shin SW, Park JS, Uh ST, Chang HS, Bae DJ, et al. Clinical Characteristics of Exacerbation-Prone Adult Asthmatics Identified by Cluster Analysis. Allergy Asthma Immunol Res. 2017; 9:483–490.

7. Sutherland ER, Goleva E, King TS, Lehman E, Stevens AD, Jackson LP, et al. Cluster analysis of obesity and asthma phenotypes. PLoS One. 2012; 7:e36631.

8. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010; 181:315–323.

9. Amelink M, de Nijs SB, de Groot JC, van Tilburg PM, van Spiegel PI, Krouwels FH, et al. Three phenotypes of adult-onset asthma. Allergy. 2013; 68:674–680.

10. Castillo JR, Peters SP, Busse WW. Asthma Exacerbations: pathogenesis, Prevention, and Treatment. J Allergy Clin Immunol Pract. 2017; 5:918–927.

11. Tan WC. Viruses in asthma exacerbations. Curr Opin Pulm Med. 2005; 11:21–26.

12. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002; 359:831–834.

13. Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med. 1998; 158:2453–2459.

14. Edwards MR, Walton RP, Jackson DJ, Feleszko W, Skevaki C, Jartti T, et al. The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. Allergy. 2017.

15. Glanville N, McLean GR, Guy B, Lecouturier V, Berry C, Girerd Y, et al. Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein. PLoS Pathog. 2013; 9:e1003669.

16. Seo KH, Bae DJ, Kim JN, Lee HS, Kim YH, Park JS, et al. Prevalence of Respiratory Viral Infections in Korean Adult Asthmatics With Acute Exacerbations: Comparison With Those With Stable State. Allergy Asthma Immunol Res. 2017; 9:491–498.